• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Accelsiors expands global footprint

Accelsiors expands global footprint

January 24, 2017
CenterWatch Staff

Accelsiors has announced the opening of a new office in Gurgaon, India. This investment will provide our biotechnology, pharmaceutical and medical device customers with greater access to patient populations in an increasingly well-regulated environment.

“Accelsiors is committed to providing our customers with a depth of medical, scientific and regulatory expertise while conducting clinical studies with utmost quality,” said Mihaly Juhasz, M.D., Accelsiors’ CEO. “Our 20 years of experience in the biosimilar sector and ability to provide stand-alone services (biometrics) has driven us to make this important investment.”

The Asian biosimilar development market is growing at a rapid pace and Accelsiors is now positioned to provide an even greater level of support to current and prospective customers. Additionally, the added headcount enables us to provide a quality-driven, scalable solution to functional service provision, specifically biometrics.

“We are honored to be a part of Accelsiors global expansion,” said Shabbir Rangwala, vice president, Operations. “Not only will Accelsiors be creating new jobs in India, but the expansion represents a renewed level of confidence in the quality of service delivery in the region.”

As the leader of the Asian Operations Team, Rangwala will oversee local operations while establishing and executing strategic growth strategies across the region.

Accelsiors is a scientifically-driven CRO committed to serving the needs of its sponsors with the highest level of quality.

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing